加味萆■分清汤治疗慢性非细菌性前列腺炎的效果

Abstract
Figure/Table
References (25)
Related Citation (15)

Download: PDF (489 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To analyze the effect of Modified Bixie Fenqing Decoction in the treatment of chronic nonbacterial prostatitis. Methods Clinical data of 80 patients with chronic nonbacterial prostatitis admitted to Department of Urology of the Fourth Hospital of Changsha City from January 2017 to March 2018 was retrospectively analyzed. According to different treatment methods, they were divided into the control group and the observation group, with 40 cases in each group. The control group was treated by Cernilton Tablets, and the observation group was treated by Modified Bixie Fenqing Decoction. The scores of National Institutes of Health chronic prostatitis symptom index (NIH-CPSI), sex hormones [testosterone (T), estradiol (E2), prolactin (PRL)] in the prostatic fluid, tumor necrosis factor alpha (TNF-α), macrophage inflammatory protein-1 alpha (MIP-1α), cyclooxygenase-2 (COX-2), prostaglandin (PGE2) and the level of urodynamics of the two groups were compared before and after treatment. Results Before treatment, there were no statistically significant differences in NIH-CPSI score and urodynamics (maximum urine flow rate and average urine flow rate) between the two groups (P ＞ 0.05). After treatment, the NIH-CPSI score of the two groups was decreased compared with that before treatment, and the urodynamics was increased compared with that before treatment. Moreover, the NIH-CPSI score of the observation group was lower than that of the control group, and the urodynamics was higher than that of the control group, the differences were statistically significant (P ＜ 0.05). Before treatment, there were no statistically significant differences in levels of sex hormone, TNF-α, MIP-1α, COX-2, PGE2 between the two groups (P ＞ 0.05). After treatment, the levels of T in prostatic fluid of the two groups were increased, while the levels of E2, TNF-α, MIP-1α, COX-2, PGE2 were decreased compared with those before treatment. The level of T of the observation group was higher than that of the control group, and the levels of E2, TNF-α, MIP-1α, COX-2 and PGE2 were lower than those of the control group, the differences were statistically signficant (P ＜ 0.05). How ever, there was no statistically significant difference of PRL levels between the two groups (P ＞ 0.05). Conclusion Modified Bixie Fenqing Decoction has good effect for the treatment of chronic nonbacterial prostatitis, which can effectively improve urine flow rate, and it is worthy of clinical popularization and application.

Key words： Modified Bixie Fenqing Decoction Chronic nonbacterial prostatitis Curative effect Urine dynamics

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	SHEN Longjiang ZUO Meiling CHEN Tao HUANG He PENG Hongliang QIAN Xiaohui

Cite this article:

SHEN Longjiang ZUO Meiling CHEN Tao HUANG He PENG Hongliang QIAN Xiaohui. Effect of Modified Bixie Fenqing Decoction in the treatment of chronic nonbacterial prostatitis[J]. 中国医药导报, 2019, 16(21): 64-68.

URL:

http://www.yiyaodaobao.com.cn/EN/ OR http://www.yiyaodaobao.com.cn/EN/Y2019/V16/I21/64

[1] 张玉军.中西医结合治疗慢性非细菌性前列腺炎58例临床观察[J].世界中西医结合杂志，2016，11（2）：198-200，203.
[2] 莫林键，陈曦，汪小明，等.Ⅲ型和Ⅳ型前列腺炎患者前列腺按摩液中锌离子浓度检测和临床价值[J].中华男科学杂志，2016，22（6）：496-500.
[3] 周萍，肖金海，江琼，等.清热利湿通淋汤联合坦索罗辛治疗慢性前列腺炎湿热下注证的疗效[J].实用医学杂志，2016，32（12）：2055-2057.
[4] 郑筱萸.中药新药临床研究指导原则（试行）[S].北京：中国医药科技出版社，2002：168-172.
[5] 吴阶平.泌尿外科学[M].济南：科学技术出版社，1993：64.
[6] 罗琳，牟晓兵，张瑾.前列腺液中锌离子、PSA及MIP-1α水平与慢性非细菌性前列腺炎患者症状的相关性[J].贵州医科大学学报，2018，43（7）：802-806.
[7] Relster MM，Holm A，Pedersen C. Plasma cytokines eotaxin，MIP-1α，MCP-4，and vascular endothelial growth factor in acute lower respiratory tract infection [J]. Apmis，2017，125（2）：148-156.
[8] 黄健，邓宏伟，陈丹，等.普适泰与地奥司明对老年慢性前列腺炎患者血清和前列腺液中MIP-2和MIP-1α的影响[J].现代生物医学进展，2017，17（25）：4920-4923.
[9] 金轶刚，陈善闻.舍尼通联合抗生素治疗慢性非细菌性前列腺炎的临床效果分析[J].中国性科学，2016，25（6）：21-23.
[10] 袁明殿.清热利湿化瘀方对前列腺炎患者前列腺液单核细胞趋化因子-1水平影响[J].中医药学报，2017，45（6）：88-91.
[11] 黄新飞，宁克勤，王庆，等.清热利湿祛瘀法治疗慢性前列腺炎的临床疗效及对患者局部免疫的影响[J].世界中医药，2017，12（12）：3023-3026.
[12] 陈天华，王长江，彭惠，等.清热利湿汤治疗慢性细菌性前列腺炎疗效分析[J].实用中医药杂志，2016，32（5）：400-402.
[13] 樊威伟，车树强.车树强治疗前列腺炎经验[J].湖南中医杂志，2018，34（6）：33-35.
[14] 杨凯，严丰，朱勇，等.曾庆琪教授从瘀论治男科病验案3则[J].环球中医药，2017，10（2）：243-245.
[15] 林玲，陈映鹤.解毒化瘀汤联合西药治疗慢性非细菌性前列腺炎的临床疗效分析[J].中国中医药科技，2017， 24（6）：767-769.
[16] 张伟，张振榆.丹参合剂联合四联疗法治疗慢性萎缩性胃炎伴幽门螺杆菌感染48例[J].西部中医药，2018，31（10）：91-94.
[17] 蒋晓芸.丹参多酚酸盐注射液治疗缺血性结肠炎的临床研究[J].中国医药科学，2018，8（24）：32-34.
[18] 马建锋，刘颖，孙立娜，等.前列腺炎患者与健康人群的血清睾酮、雌二醇水平的临床比较[J].中国性科学，2017， 26（4）：25-26.
[19] 程敏捷，李红.萘哌地尔对老年前列腺炎患者血清及前列腺液MIP-2，MIP-1α水平的影响[J].中国生化药物杂志，2016，36（4）：95-96，99.
[20] 戴应和，龙小琴，刘晨琪，等.角叉菜胶诱导慢性非细菌性前列腺炎动物模型的制备与评价[J].中国实验动物学报，2017，25（5）：544-550.
[21] 吴炜景，张家敏，李立平，等.以TNF-α刺激A549细胞构建急性肺损伤细胞模型[J].中国医药科学，2017，7（17）：30-32.
[22] Tsubaki M，Mashimo K，Takeda T，et al. Statins inhibited the MIP-1α expression via inhibition of Ras/ERK and Ras/Akt pathways in myeloma cells [J]. Biomed Pharmacother，2016，13（78）：23-29.
[23] 尤传静，吴强，张浩，等.中药清浊汤对慢性非细菌性前列腺炎大鼠前列腺组织形态及COX-2、NF-KB表达的影响[J].中国男科学杂志，2017，31（5）：7-11. doi：10. 3969/j.issn.1008-0848.2017.05.002.
[24] 王鹏，吴绍钦，黄杰，等.中药联合超声电导前列腺治疗仪治疗慢性非细菌性前列腺炎的效果[J].中国医药导报，2017，14（28）：97-100.
[25] 张瑞，燕培荣，黄勤洲，等.前列腺按摩液中炎性因子联合降钙素原检测对细菌性前列腺炎的诊断价值[J].国际泌尿系统杂志，2016，36（5）：708-711. doi：10.3760/cma.j.issn.1673-4416.2016.05.020.